Article
An enterococcal phage protein broadly inhibits type IV restriction enzymes involved in antiphage defense
2023-11-16
Abstract excerpt
<h4>ABSTRACT</h4> The prevalence of multidrug resistant (MDR) bacterial infections continues to rise as the development of antibiotics needed to combat these infections remains stagnant. MDR enterococci are a major contributor to this crisis. A potential therapeutic approach for combating MDR enterococci is bacteriophage (phage) therapy, which uses lytic viruses to infect and kill pathogenic bacteria. While phage...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced biosensing and bioanalysis techniques
- Antimicrobial Resistance in Staphylococcus
- Bacteriophages and microbial interactions
- CRISPR and Genetic Engineering
- Enterobacteriaceae and Cronobacter Research
- Monoclonal and Polyclonal Antibodies Research
- RNA and protein synthesis mechanisms
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 040714b1-1eb2-5a44-8633-416929905f51
- DOI
- 10.1101/2023.11.16.567456
